These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3864640)

  • 1. Enoxacin in the treatment of bronchopulmonary infections.
    Joet FP; Nourrit J; Frances Y; Arnaud A
    Eur J Clin Microbiol; 1985 Oct; 4(5):512-3. PubMed ID: 3864640
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of the 4-quinolone enoxacin on plasma theophylline concentrations.
    Wijnands WJ; Vree TB; Van Herwaarden CL
    Pharm Weekbl Sci; 1986 Feb; 8(1):42-5. PubMed ID: 3457357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxacin raises plasma theophylline concentrations.
    Wijnands WJ; van Herwaarden CL; Vree TB
    Lancet; 1984 Jul; 2(8394):108-9. PubMed ID: 6145999
    [No Abstract]   [Full Text] [Related]  

  • 4. Enoxacin in lower respiratory tract infections.
    Wijnands WJ; van Griethuysen AJ; Vree TB; Van Klingeren B; van Herwaarden CL
    J Antimicrob Chemother; 1986 Dec; 18(6):719-27. PubMed ID: 3469179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxacin treatment of urinary tract infections.
    Thomas MG; Ellis-Pegler RB
    J Antimicrob Chemother; 1985 Jun; 15(6):759-63. PubMed ID: 3861605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of the quinolones.
    Neu HC
    Lancet; 1987 Dec; 2(8571):1319-22. PubMed ID: 2890913
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative clinical study of enoxacin (AT-2266, ENX) and cefaclor (CCL) in chronic respiratory tract infections by a double-blind method].
    Hara K; Saito A; Izumikawa K; Yamaguchi K; Suzuyama Y; Shigeno Y; Watanabe K; Komori M; Yamashita K; Miyazaki Y
    Kansenshogaku Zasshi; 1984 Oct; 58(10):1046-72. PubMed ID: 6442319
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral enoxacin used to cure spinal osteomyelitis due to aminoglycoside-resistant Pseudomonas aeruginosa.
    Bailey RR; Newman E
    N Z Med J; 1985 Jun; 98(781):508. PubMed ID: 3859782
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of enoxacin in a patient with cystic fibrosis.
    Miller MG; Ghoneim AT; Littlewood JM
    Lancet; 1985 Mar; 1(8429):646. PubMed ID: 2857989
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is trovafloxacin an antibiotic exclusively for the treatment of respiratory infections?].
    Garau J
    Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():43-6; discussion 47-52. PubMed ID: 10344098
    [No Abstract]   [Full Text] [Related]  

  • 11. Enoxacin in the treatment of lower respiratory tract infections.
    Philip-Joet F; Nourrit J; Frances Y; Arnaud A
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():125-9. PubMed ID: 3258863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of treatment of bacterial inflammation of the skin with enoxacin].
    Mensing H
    Infection; 1986; 14 Suppl 3():S217-8. PubMed ID: 3531029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxacin (Parke-Davis).
    Infection; 1986; 14 Suppl 3():S181-220. PubMed ID: 3463541
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of enoxacin in the treatment of bacterial infections of the skin with regards to photosensitization.
    Petri H; Tronnier H
    Infection; 1986; 14 Suppl 3():S213-6. PubMed ID: 3463546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Neisseria gonorrhoeae to enoxacin.
    Wagenvoort JH; van der Willigen AH; van Vliet HJ; Michel MF; Van Klingeren B
    J Antimicrob Chemother; 1986 Sep; 18(3):429. PubMed ID: 3464584
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and pharmacokinetic studies on enoxacin in ear, nose and throat infections.
    Federspil PJ; Lind A; Tiesler E; Schmidt B
    Infection; 1986; 14 Suppl 3():S211-2. PubMed ID: 3463545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxacin in the treatment of sexually transmitted diseases.
    Siboulet A; Bohbot JM; Catalan F
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():119-24. PubMed ID: 3283097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of enoxacin and co-trimoxazole in the treatment of patients with complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():113-8. PubMed ID: 3258862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxacin: clinical results in lower respiratory tract infections.
    Grassi C; Mangiarotti P; Dal Prà ML
    J Chemother; 1989 Jul; 1(4 Suppl):790-2. PubMed ID: 16312641
    [No Abstract]   [Full Text] [Related]  

  • 20. Enoxacin pharmacokinetics and efficacy in CF-1 mice.
    Chartrand SA; Scribner RK; Marks MI; Dice J
    J Antimicrob Chemother; 1987 Feb; 19(2):221-4. PubMed ID: 3553134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.